2024 Speakers

Adam Smith

Director - Biologics Manufacturing

Telix Pharmaceuticals

Amir Golan

Vice President, Radioligand Therapy Platform

Novartis

Amir Iravani

Associate Professor

University of Washington- Fred Hutchinson Cancer Center, Seattle, WA

Amos Hedt

Chief Business Officer

Perspective Therapeutics

Andreas Goutopoulos

CEO

Actithera

Andrew Thompson

Radiation Oncologist

Beaumont Health System

Anna Karmann

Chief Medical Officer

AdvanCell

Christopher Leamon

Chief Scientific Officer

Fusion Pharmaceuticals

Daniel Thorek

Associate Professor of Radiology

Washington University School of Medicine in St. Louis

David Ulmert

Director, Preclinical Theranostics Program at UCLA

University of California Los Angeles

Elcin Zan

Assistant Professor

Weill Cornell University

Eugene Kwon

Professor

Mayo Clinic

Funan Huang

Senior Global Medical Leader

Bayer

Jack Hoppin

Chief Executive Officer

Ratio Therapeutics

Jacob Houghton

Assistant Professor

Stony Brook School of Medicine

Jarrod Longcor

Chief Operating Officer

Cellectar Biosciences Inc.

Jeremie Calais

Director of Theranostics Research Program

University of California Los Angeles

Josh Mailman

President

NorCal CarciNET

Kemp Dolliver

Director of Research and Senior Analyst

Brookline Capital Markets

Manfred Rüdiger

Chief Executive Officer

Ariceum Therapeutics

Mary Jessel

Senior Vice President, Global Medical Affairs

Telix Pharmaceuticals

Matthew Korn

Global Medical Lead

Bayer

Michael Nickels

Director, Cyclotron Facility

Washington University School of Medicine

Mike Wardach

Senior Regulatory Sciences Advisor

Telix Pharmaceuticals

Nadine Mallak

Associate Professor

OHSU - Oregon Health & Science University

Nicholas Pullen

Chief Scientific Officer

ARTBIO

Othon Gervasio

Senior Medical Director

Clarity Pharmaceuticals

Paul Feldman

Chief Scientific Officer

Aktis Oncology

Philip Kantoff

Chief Executive Officer & Co-Founder

Convergent Therapeutics

Reinier Hernandez

Assistant Professor

University of Wisconsin-Madison

Sarah Cheal

Assistant Professor

Weill Cornell Medical College

Scott Tagawa

Professor

Weill Cornell University

Shankar Vallabhajosula

Vice President, Radiopharmaceutical Sciences

Convergent Therapeutics

Simon Read

Chief Executive Officer

Mariana Oncology

Simron Singh

Associate Professor

Sunnybrook Research Institute

SUJIET PUTHENVEETIL

Director

AstraZeneca

Tobias Heinrich

Head of Laboratory

Bayer

Vishal Kapur

Executive Director RLT

Novartis

Volker Wagner

Chief Medical Officer

OranoMed

William van der Touw

Senior Vice President - Research & Development

Actinium Pharmaceuticals

Ying Cai

Director - Supply Chain

Ashvattha Therapeutics

Zachary Morris

Associate Professor and Vice-Chair

University of Wisconsin-Madison